Ipamorelin: Dosage, Benefits & Research Guide
Also known as: NNC 26-0161
What is Ipamorelin?
Ipamorelin is a synthetic pentapeptide (Aib-His-D-2Nal-D-Phe-Lys-NH2) that acts as a selective agonist of the growth hormone secretagogue receptor (GHS-R1a/ghrelin receptor). Its mechanism involves binding the ghrelin receptor on anterior pituitary somatotrophs to trigger calcium influx and GH granule exocytosis. What distinguishes ipamorelin from earlier ghrelin mimetics is its remarkable selectivity: clinical studies by Raun et al. (European Journal of Endocrinology, 1998) demonstrated that ipamorelin stimulates GH release in a dose-dependent manner without significantly affecting cortisol, prolactin, FSH, LH, or TSH levels, even at high doses. This selectivity profile makes it one of the cleanest GH secretagogues available for research. In bone metabolism research, Anderson et al. (Bone, 2001) showed that ipamorelin administration in ovariectomized rat models increased bone mineral content and bone formation markers, suggesting anabolic effects on skeletal tissue independent of IGF-1 elevation. The peptide has also been studied in post-operative recovery models, where it demonstrated prokinetic effects on gastric motility. Compared to GHRP-6 and GHRP-2, which also activate the ghrelin receptor but additionally stimulate appetite and affect cortisol/prolactin levels, ipamorelin provides a more isolated GH response. Compared to hexarelin, another GHRP, ipamorelin shows less desensitization with repeated dosing. Store lyophilized powder at -20C; reconstitute with bacteriostatic water and refrigerate at 2-8C for up to 28 days. Ipamorelin is investigated by endocrinology labs, bone metabolism research centers, orthopedic research departments, and gastrointestinal motility researchers.
Ipamorelin Research Applications
In published and preclinical research, Ipamorelin has been studied across the following areas:
- Bone metabolism and structural integrity
- Muscle preservation and anabolism
- Glucose regulation studies
- Post-operative recovery research
Ipamorelin in Research: Reconstitution & Study Concentrations
Ipamorelin is a pentapeptide growth-hormone secretagogue noted in research for selectivity — stimulating GH release with minimal effect on cortisol or prolactin. It is frequently studied alongside GHRH analogs such as CJC-1295. The lyophilized peptide is reconstituted with bacteriostatic water; research concentration is model-specific.
Worked example: a 5mg vial reconstituted with 2 mL of bacteriostatic water yields 2.50 mg/mL.
Open the reconstitution calculatorHow Ipamorelin Compares
Researchers frequently evaluate Ipamorelin alongside related compounds:
- Ipamorelin vs CJC-1295 (no DAC) — GHRH analog often paired with ipamorelin in research
- Ipamorelin vs GHRP-6 — less selective secretagogue